🔎 Trials Near Me

Akèy › Kansè Utèrin › Massachusetts › Boston

Etid klinik pou Kansè Utèrin nan Boston, MA

5 etid pou Kansè Utèrin ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Ap rekriteFaz 3
  • Research Site, Boston
Laj 18 ak plis · Fanm · Mizajou Sep 3, 2026 · NCT06989112

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Ap rekriteFaz 1/2
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT05579366

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Ap rekriteFaz 2
  • Tufts Medical Center, Boston
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797

Azenosertib in Uterine Serous Carcinoma: Biomarker Study

Ap rekriteFaz 2
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Fanm · Mizajou Mar 2, 2026 · NCT06369155

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

Ap rekriteFaz 2
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Fanm · Mizajou Nov 5, 2025 · NCT06677190

Etid Kansè Utèrin nan lòt vil

Lòt etid nan Boston

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.